Table 1 Preveous reports of adenocarcinoma of the gastrointestinal type in the ovary arising from a MCT
Case | Source | Age | Tumor marker | Tumor size (cm) | Surgical procedure | FIGO stage | Adjuvant therapy | Follow up |
|---|---|---|---|---|---|---|---|---|
1 | G.Ueda et al. (1993) | 62 | N.E. | 35 | TAH+BSO | Ia | FAMT | 15 years |
2 | Fishman A et al. (1998) | 38 | CEA: 40 ng/ml CA 125: 80 U/ml CA153: 60 U/ml | 20 x 13 x 8.5 | TAH+BSO+OMT +appendectomy | IIIc | 5FU Leucovorin | DOD 3 month after surgery |
3 | Levine DA et.al (2004) | 37 | CEA: 11.2 ng/ml CA 125,AFP, HCG: WNL | 15 x 12 x 11 | Unilateral SO +OMT +PLN+PAN | Ia | none | 40 month |
4 | Kushima M (2004) | 52 | CA19-9: 109 U/ml SLX: 58.5 U/ml CA125: 36 U/ml CA72-4: 19 U/ml | 6.4 x 4.8 x 2.8 | Bilateral SO | Ia | none | 31 month |
5 | KJ Min et.al (2006) | 77 | CA125: 72 U/ml | 17 x 14 x 2 | TAH+BSO | Ia | none | 12 month |
6 | Gunney M et.al (2006) | 38 | CEA: WNL CA1 25: 99.1 U/ml CA19-9: >1000 U/ml | N.D. | TAH+BSO+OMT +PLN+PAN | Ia | none | N.D. |
7 | present case | 49 | CEA: 6.9 ng/ml CA 125: 20 U/ml CA19-9: 3.8 U/ml SCC: 1.1 ng/ml | 6.7 x 5.7 | TAH+BSO+OMT | Ic(b) | none | 5 years |